Sophie Caseby
Sophie Caseby, value and access policy manager, the Association of the British Pharmaceutical Industry (ABPI)
CommentPatients pay the price when the NHS undervalues medicines
The debate over medicines spending should focus on how to fund innovation and improve patient access, rather than framing investment in treatments as a threat to other NHS priorities